Regional Gain and Global Loss of 5-hydroxymethylcytosine Coexist in Genitourinary Cancers and Regulate Different Oncogenic Pathways

Overview

Journal Clin Epigenetics

Publisher Biomed Central

Specialty Genetics

Date 2022 Sep 20

PMID 36127710

Authors

Jie Qi

Yue Shi

Yezhen Tan

Qi Zhang

Jianye Zhang

Jilu Wang

Cong Huang

Weimin Ci

Affiliations

Soon will be listed here.

Abstract

Background: DNA 5-hydroxymethylcytosine (5hmC) is produced by dynamic 5mC oxidation process contributing to tissue specification, and loss of 5hmC has been reported in multiple cancers including genitourinary cancers. However, 5hmC is also cell-type specific, and its variability may exist between differentiated tumor cells and cancer stem cells. Thus, cancer-associated changes in 5hmC may be contributed by distinct sets of tumor cells within the tumor tissues.

Results: Here, we applied a sensitive immunoprecipitation-based method (hMeDIP-seq) to analyze 5hmC changes during genitourinary carcinogenesis (including prostate, urothelial and kidney). We confirmed the tissue-specific distribution of 5hmC in genitourinary tissues and identified regional gain and global loss of 5hmC coexisting in genitourinary cancers. The genes with gain of 5hmC during tumorigenesis were functionally enriched in regulating stemness and hypoxia, whereas were associated with poor clinical prognosis irrespective of their differences in tumor type. We identified that gain of 5hmC occurred in soft fibrin gel-induced 3D tumor spheres with a tumor-repopulating phenotype in two prostate cancer cell lines, 22RV1 and PC3, compared with conventional two-dimensional (2D) rigid dishes. Then, we defined a malignant signature derived from the differentially hydroxymethylated regions affected genes of cancer stem-like cells, which could predict a worse clinical outcome and identified phenotypically malignant populations of cells from prostate cancer tumors. Notably, an oxidation-resistant vitamin C derivative, ascorbyl phosphate magnesium, restored 5hmC and killed the cancer stem cell-like cells leading to apoptosis in prostate cancer cell lines.

Conclusions: Collectively, our study dissects the regional gain of 5hmC in maintaining cancer stem-like cells and related to poor prognosis, which provides proof of concept for an epigenetic differentiation therapy with vitamin C by 5hmC reprogramming.

Citing Articles

cfDNA hydroxymethylcytosine profiling for detection metastasis and recurrence of Esophageal Squamous Cell Carcinoma.

Kuerban S, Chen H, Chen L, Zhang L, Li X, Zhen B World J Surg Oncol. 2025; 23(1):90.

PMID: 40089765 DOI: 10.1186/s12957-025-03747-9.

Genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA as noninvasive diagnostic markers for gastric cancer.

Fu Y, Jiang J, Wu Y, Cao D, Jia Z, Zhang Y Gastric Cancer. 2024; 27(4):735-746.

PMID: 38584223 DOI: 10.1007/s10120-024-01493-7.

Methylomics and cancer: the current state of methylation profiling and marker development for clinical care.

Liu C, Tang H, Hu N, Li T Cancer Cell Int. 2023; 23(1):242.

PMID: 37840147 PMC: 10577916. DOI: 10.1186/s12935-023-03074-7.

References

Feinberg A, Koldobskiy M, Gondor A . Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat Rev Genet. 2016; 17(5):284-99. PMC: 4888057. DOI: 10.1038/nrg.2016.13. View

Liu J, Tan Y, Zhang H, Zhang Y, Xu P, Chen J . Soft fibrin gels promote selection and growth of tumorigenic cells. Nat Mater. 2012; 11(8):734-41. PMC: 3405191. DOI: 10.1038/nmat3361. View

Smith B, Balanis N, Nanjundiah A, Sheu K, Tsai B, Zhang Q . A Human Adult Stem Cell Signature Marks Aggressive Variants across Epithelial Cancers. Cell Rep. 2018; 24(12):3353-3366.e5. PMC: 6382070. DOI: 10.1016/j.celrep.2018.08.062. View

Zhang J, Han X, Gao C, Xing Y, Qi Z, Liu R . 5-Hydroxymethylome in Circulating Cell-free DNA as A Potential Biomarker for Non-small-cell Lung Cancer. Genomics Proteomics Bioinformatics. 2018; 16(3):187-199. PMC: 6076378. DOI: 10.1016/j.gpb.2018.06.002. View

Khalid S, Basulaiman B, Emack J, Booth C, Duran I, Robinson A . Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis. Eur Urol Open Sci. 2021; 21:61-68. PMC: 8317902. DOI: 10.1016/j.euros.2020.08.008. View

Sun D, Guan X, Moran A, Wu L, Qian D, Schedin P . Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data. Nat Biotechnol. 2021; 40(4):527-538. PMC: 9010342. DOI: 10.1038/s41587-021-01091-3. View

Zhang Y, Liu T, Meyer C, Eeckhoute J, Johnson D, Bernstein B . Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008; 9(9):R137. PMC: 2592715. DOI: 10.1186/gb-2008-9-9-r137. View

Young I, Wu B, Andricovich J, Chuang S, Li R, Tzatsos A . Differentiation of fetal hematopoietic stem cells requires ARID4B to restrict autocrine KITLG/KIT-Src signaling. Cell Rep. 2021; 37(8):110036. PMC: 8722094. DOI: 10.1016/j.celrep.2021.110036. View

Liu Y, Lv J, Liang X, Yin X, Zhang L, Chen D . Fibrin Stiffness Mediates Dormancy of Tumor-Repopulating Cells via a Cdc42-Driven Tet2 Epigenetic Program. Cancer Res. 2018; 78(14):3926-3937. DOI: 10.1158/0008-5472.CAN-17-3719. View

10.

Ramirez F, Dundar F, Diehl S, Gruning B, Manke T . deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res. 2014; 42(Web Server issue):W187-91. PMC: 4086134. DOI: 10.1093/nar/gku365. View

11.

Cantarini M, de la Monte S, Pang M, Tong M, DErrico A, Trevisani F . Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology. 2006; 44(2):446-57. DOI: 10.1002/hep.21272. View

12.

Anders S, Pyl P, Huber W . HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 2014; 31(2):166-9. PMC: 4287950. DOI: 10.1093/bioinformatics/btu638. View

13.

Chen K, Zhang J, Guo Z, Ma Q, Xu Z, Zhou Y . Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer. Cell Res. 2015; 26(1):103-18. PMC: 4816137. DOI: 10.1038/cr.2015.150. View

14.

Chen S, Zhu G, Yang Y, Wang F, Xiao Y, Zhang N . Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat Cell Biol. 2021; 23(1):87-98. DOI: 10.1038/s41556-020-00613-6. View

15.

Zhang Q, Tan Y, Zhang J, Shi Y, Qi J, Zou D . Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in Muscle-Invasive Bladder Cancer. Front Immunol. 2022; 13:782982. PMC: 9035667. DOI: 10.3389/fimmu.2022.782982. View

16.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

17.

Ribeiro F, Fabris C, Bendet I, Lugon J . Survival of lupus patients on dialysis: a Brazilian cohort. Rheumatology (Oxford). 2012; 52(3):494-500. DOI: 10.1093/rheumatology/kes298. View

18.

. Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2022. Nucleic Acids Res. 2021; 50(D1):D27-D38. PMC: 8728233. DOI: 10.1093/nar/gkab951. View

19.

Debeb B, Zhang X, Krishnamurthy S, Gao H, Cohen E, Li L . Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells. Mol Cancer. 2010; 9:180. PMC: 2915978. DOI: 10.1186/1476-4598-9-180. View

20.

DeSantis C, Lin C, Mariotto A, Siegel R, Stein K, Kramer J . Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014; 64(4):252-71. DOI: 10.3322/caac.21235. View